CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $754,917 | -66.7% | 64,578 | -47.0% | 0.00% | -83.3% |
| Q4 2022 | $2,266,838 | +163.6% | 121,873 | -0.6% | 0.01% | +100.0% |
| Q2 2022 | $860,000 | -32.5% | 122,638 | -20.2% | 0.01% | -45.5% |
| Q1 2022 | $1,274,000 | +5.6% | 153,709 | -13.8% | 0.01% | +22.2% |
| Q4 2021 | $1,207,000 | +169.4% | 178,320 | +111.0% | 0.01% | +50.0% |
| Q3 2021 | $448,000 | +75.7% | 84,502 | +90.9% | 0.01% | +100.0% |
| Q2 2021 | $255,000 | +94.7% | 44,264 | +30.1% | 0.00% | -40.0% |
| Q1 2020 | $131,000 | – | 34,024 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |